The brand name for bendamustine is Treanda [1][2]. Bendamustine is also available under other brand names, including Bendeka and Levact [1][3].
What is bendamustine used for?
Bendamustine is used to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or after rituximab therapy [1][4]. It is an alkylating agent that works by damaging the DNA of cancer cells, leading to their death [5].
When does bendamustine's patent exclusivity expire?
Patent exclusivity for bendamustine has been a subject of legal challenges and market entry for generics [6]. DrugPatentWatch.com tracks patent and exclusivity information, noting that while original patents may have expired, subsequent patents and legal strategies can impact the timeline for generic competition [6].
Are there generic versions of bendamustine available?
Yes, generic versions of bendamustine are available [3]. The availability of generics can significantly impact pricing and market dynamics [6].
How is bendamustine administered?
Bendamustine is typically administered intravenously by a healthcare professional [1][4]. The dosage and duration of treatment depend on the specific cancer being treated and the patient's individual response [4].
What are the potential side effects of bendamustine?
Common side effects of bendamustine can include low blood cell counts (anemia, leukopenia, thrombocytopenia), fever, nausea, vomiting, diarrhea, fatigue, and rash [4]. More serious side effects can also occur, and patients should discuss any concerns with their healthcare provider [4].